A phase II trial of thalidomide (Thal) and procarbazine (Pro) in adults with recurrent or progressive malignant gliomas (MG)

被引：0
|
作者：
Lesser, G. J. [1 ]
Stieber, V. [1 ]
Case, D. [1 ]
Enevold, G. [1 ]
Rosdhal, R. [1 ]
Tatter, S. [1 ]
Ellis, T. [1 ]
McMullen, K. [1 ]
Shaw, E. [1 ]
机构：
[1] Wake Forest Univ, Winston Salem, NC 27109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2067
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
    Peters, Katherine B.
    Lipp, Eric S.
    Miller, Elizabeth
    Herndon, James E., II
    McSherry, Frances
    Desjardins, Annick
    Reardon, David A.
    Friedman, Henry S.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (02) : 349 - 356
  • [22] Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
    Katherine B. Peters
    Eric S. Lipp
    Elizabeth Miller
    James E. Herndon
    Frances McSherry
    Annick Desjardins
    David A. Reardon
    Henry S. Friedman
    Journal of Neuro-Oncology, 2018, 137 : 349 - 356
  • [23] Efficacy of fotemustine in recurrent/progressive gliomas:: A phase II study
    Laguzzi, E.
    Rudà, R.
    Trevisan, E.
    Guarneri, D.
    Mocellini, C.
    Soffietti, R.
    NEURO-ONCOLOGY, 2006, 8 (04) : 347 - 347
  • [24] Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas
    Ahluwalia, Manmeet S.
    Patton, Carol
    Stevens, Glen
    Tekautz, Tanya
    Angelov, Lilyana
    Vogelbaum, Michael A.
    Weil, Robert J.
    Chao, Sam
    Elson, Paul
    Suh, John H.
    Barnett, Gene H.
    Peereboom, David M.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 102 (02) : 317 - 321
  • [25] Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas
    Manmeet S. Ahluwalia
    Carol Patton
    Glen Stevens
    Tanya Tekautz
    Lilyana Angelov
    Michael A. Vogelbaum
    Robert J. Weil
    Sam Chao
    Paul Elson
    John H. Suh
    Gene H. Barnett
    David M. Peereboom
    Journal of Neuro-Oncology, 2011, 102 : 317 - 321
  • [26] Phase 1 Clinical Trial of Intratumoral Reovirus Infusion for the Treatment of Recurrent Malignant Gliomas in Adults
    Kicielinski, Kimberly P.
    Chiocca, E. Antonio
    Yu, John S.
    Gill, George M.
    Coffey, Matt
    Markert, James M.
    MOLECULAR THERAPY, 2014, 22 (05) : 1056 - 1062
  • [27] A phase I trial of Avonex for patients with recurrent malignant gliomas
    Wen, PY
    Robertson, M
    ONeil, A
    Loeffler, JS
    Black, PM
    Fine, HA
    NEUROLOGY, 1997, 48 (03) : 1003 - 1003
  • [28] PHASE I TRIAL OF TEMSIROLIMUS (TEM) AND PERIFOSINE (PER) FOR RECURRENT OR PROGRESSIVE MALIGNANT GLIOMA (MG)
    Kaley, Thomas J.
    Pentsova, Elena
    Omuro, Antonio
    Mellinghoff, Ingo
    Nolan, Craig
    Gavrilovic, Igor
    DeAngelis, Lisa M.
    Holland, Eric
    Lacouture, Mario E.
    Ludwig, Emmy
    Lassman, Andrew B.
    NEURO-ONCOLOGY, 2012, 14 : 104 - 104
  • [29] Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients
    Silvani, A
    Eoli, M
    Salmaggi, A
    Lamperti, E
    Maccagnano, E
    Broggi, G
    Boiardi, A
    JOURNAL OF NEURO-ONCOLOGY, 2004, 66 (1-2) : 203 - 208
  • [30] Phase II Trial of Cisplatin Plus Temozolomide, in Recurrent and Progressive Malignant Glioma Patients
    Antonio Silvani
    Marica Eoli
    Andrea Salmaggi
    Elena Lamperti
    Elio Maccagnano
    Giovanni Broggi
    Amerigo Boiardi
    Journal of Neuro-Oncology, 2004, 66 : 203 - 208
12345